CN1067258C - Medicinal preparation with extractive from yangtao root and preparing process thereof - Google Patents
Medicinal preparation with extractive from yangtao root and preparing process thereof Download PDFInfo
- Publication number
- CN1067258C CN1067258C CN96120260A CN96120260A CN1067258C CN 1067258 C CN1067258 C CN 1067258C CN 96120260 A CN96120260 A CN 96120260A CN 96120260 A CN96120260 A CN 96120260A CN 1067258 C CN1067258 C CN 1067258C
- Authority
- CN
- China
- Prior art keywords
- precipitate
- alcohol
- add
- ethanol
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 69
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 44
- 239000002244 precipitate Substances 0.000 claims description 33
- 239000003814 drug Substances 0.000 claims description 32
- 239000006228 supernatant Substances 0.000 claims description 22
- 238000005406 washing Methods 0.000 claims description 22
- 244000298715 Actinidia chinensis Species 0.000 claims description 20
- 229960004756 ethanol Drugs 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 18
- 238000012546 transfer Methods 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 12
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 11
- 238000007598 dipping method Methods 0.000 claims description 11
- 230000002829 reductive effect Effects 0.000 claims description 11
- 208000002672 hepatitis B Diseases 0.000 claims description 3
- 208000030507 AIDS Diseases 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 239000000284 extract Substances 0.000 abstract description 10
- 241000219068 Actinidia Species 0.000 abstract description 6
- 206010028980 Neoplasm Diseases 0.000 abstract description 6
- 230000002708 enhancing effect Effects 0.000 abstract description 6
- 230000036737 immune function Effects 0.000 abstract description 5
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 208000015181 infectious disease Diseases 0.000 abstract description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 abstract 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 239000007924 injection Substances 0.000 description 13
- 238000002347 injection Methods 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- 239000000825 pharmaceutical preparation Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 229940079593 drug Drugs 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- 229920001282 polysaccharide Polymers 0.000 description 6
- 239000005017 polysaccharide Substances 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- -1 suspensoid Substances 0.000 description 5
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 4
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 238000004382 potting Methods 0.000 description 4
- 102000003815 Interleukin-11 Human genes 0.000 description 3
- 108090000177 Interleukin-11 Proteins 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 230000002924 anti-infective effect Effects 0.000 description 3
- 239000003889 eye drop Substances 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 229940074383 interleukin-11 Drugs 0.000 description 3
- 210000000822 natural killer cell Anatomy 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 102000000588 Interleukin-2 Human genes 0.000 description 2
- 108010002350 Interleukin-2 Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 210000004366 CD4-positive T-lymphocyte Anatomy 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 1
- 241000450599 DNA viruses Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000005100 Herpetic Keratitis Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102100030703 Interleukin-22 Human genes 0.000 description 1
- 206010073938 Ophthalmic herpes simplex Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 241000711975 Vesicular stomatitis virus Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229960004397 cyclophosphamide Drugs 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000027950 fever generation Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 201000010884 herpes simplex virus keratitis Diseases 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 108010074109 interleukin-22 Proteins 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to an effective position extract product of Chinese gooseberry root and a medical preparation thereof. The medical preparation has the effects of supporting vital qi, enhancing immunological function, removing epidemic diseases, enhancing the infection resisting capability of a machine body, dispersing swell, dissipating stasis and inhibiting tumor. The present invention also relates to a method for extracting the effective position extract product of Chinese gooseberry root and a method for preparing the medical preparation of the effective position extract product of Chinese gooseberry root.
Description
The present invention relates to a kind of effective part extract and pharmaceutical preparation thereof of Radix Actinidiae Chinensis, this medicine have encourage healthy trends, raise immunity; The effect of epidemic disease, enhancing body anti-infective ability and dispersing swelling and dissipating binds, the inhibition tumor of dispelling the invention still further relates to the preparation method of Radix Actinidiae Chinensis effective part extract and pharmaceutical preparation thereof.
Radix Actinidiae Chinensis (Radix Actinidia Chinensis) has another name called Radix Actinidiae Chinensis, and is cool in nature, nontoxic, taken in China's pharmacopeia (version in 1977) as Chinese crude drug.China is the original producton location of A.chinensis Planch., it is utilized with a long history.Promptly on the books in " elegant " book before two thousand years, successive dynasties such as supplement to the Herbal then, " Kaibao Bencao ", Compendium of Material Medica, " plant name figure examines in fact " medicine masterpiece is all on the books to it.Its fruit succulence, the traditional Chinese medical science think have regulating QI of the middle-JIAO, promote the production of body fluid moisturize, analgesic relieving restlessness function, its root has effects such as heat-clearing and toxic substances removing, blood circulation promoting and dispersing pathogen accumulation, expelling wind and removing dampness, parasite killing, cure mainly heat stops up regurgitation, furuncle scrofula, stranguria with turbid discharge leukorrhagia, hepatitis tumor etc.
In recent years to existing bibliographical informations such as the chemical composition analysis of ovateleaf actinidia leaf root, pharmacological evaluation, for example, Li Shuhua etc. have reported the regulating action of the oligosaccharide that extracts (being called for short AKOS) to immune function of mice from the root of ovateleaf actinidia leaf, the result shows that AKOS is a kind of effective immunomodulator, has certain meaning [Norman Bethune Medical University's journal for enhancing body's immunological function, the 1990,16 (4), the 350th page]; Li Pingyas etc. produce the ovateleaf actinidia leaf root from the Changbai Mountain, separate obtaining two white monomers, are accredited as Canis familiaris L. Fructus Jujubae trisaccharide through spectrum analysis and chemical method.To the interim research of the pharmacology of A.chinensis Planch., the inventor has made partly report, but up to the present, Shang Weijian is about making preparation with A.chinensis Planch. root effective site, and by experiment in vivo and vitro to its pharmacology and the clinical bibliographical information that carries out systematic study.Although the research of Fructus actinidiae chinensis has been reported a lot, but, because Fructus actinidiae chinensis is of a great variety, and the contained effective ingredient complexity of its root, the pharmacological action that is had also has nothing in common with each other, therefore, the effective site of Fructus actinidiae chinensis is extracted and preparation research, and further pharmacology and clinical research are current important subject.Particularly for the extraction of Chinese medicine with separate, to consider the purity and the structure of its effective ingredient on the one hand, also to consider the effectiveness of extract on the other hand, usually the two is difficult to reach unified, in this case, extracting effective site and prepare the extensive and respond well pharmaceutical preparation of a kind of curative effect from Radix Actinidiae Chinensis, is the technical barrier that current this field need solve.
The present invention seeks to extract a kind of effective site, make pharmaceutical preparation from the root of A.chinensis Planch..Described pharmaceutical preparation have encourage healthy trends, raise immunity; The effect of epidemic disease, enhancing body anti-infective ability and dispersing swelling and dissipating binds, the inhibition tumor of dispelling.
Another object of the present invention provides a kind of method of extracting the effective site with described specific pharmacologic action from the root of A.chinensis Planch..
Another object of the present invention provides a kind of method for preparing medicine with A.chinensis Planch. root effective site.
Pharmaceutical preparation of the present invention contains the A.chinensis Planch. root polysaccharide total extract for the treatment of effective dose, preferably contains the A.chinensis Planch. root polysaccharide total extract of 10-80% weight ratio.
Pharmaceutical preparation of the present invention contains the effective site of extracting from Chinese Radix Actinidiae Chinensis portion with following method of treatment effective dose:
Get the Fructus actinidiae chinensis heel piece, add alcohol dipping 1-3 time that 2-8 doubly measures 20-50%, each 18-30 hour, get supernatant, merge, add ethanol and transfer to that to contain amount of alcohol be 60-95%, leave standstill, centrifugal, precipitate is also respectively washed once with ethanol, dehydrated alcohol that 2-7 doubly measures 50-80%, discards washing liquid, precipitate adds 2-4 again and doubly measures the ether washing once, discard ether solution, the precipitate reduced pressure at room temperature, grind powder.
Pharmaceutical preparation of the present invention preferably contains the effective site of extracting from Chinese Radix Actinidiae Chinensis portion with following method of 20-70% weight ratio:
Get the Fructus actinidiae chinensis heel piece, add alcohol dipping 1-3 time that 3-6 doubly measures 25-40%, each 20-28 hour, get supernatant, merge, add ethanol and transfer to that to contain amount of alcohol be that 65-80% leaves standstill, centrifugal, precipitate is also respectively washed once with ethanol, dehydrated alcohol that 3-6 doubly measures 60-78%, discard washing liquid, precipitate adds 2-4 again and doubly measures the ether washing once, discards ether solution, the precipitate reduced pressure at room temperature, grind powder.
Pharmaceutical preparation of the present invention preferably contains the effective site of extracting from Chinese Radix Actinidiae Chinensis portion with following method of 30-65% weight ratio:
Get the Fructus actinidiae chinensis heel piece, clean, add the alcohol dipping 2 times of 5 times of amounts 30%, each 24 hours, leave standstill, get supernatant, merge, add ethanol and transfer to that to contain amount of alcohol be 72%, left standstill 24 hours, centrifugal, precipitate is also respectively washed once with ethanol, the dehydrated alcohol of 5 times of amounts 72%, discards washing liquid, precipitate adds the washing of 3 times of amount ether once again, discard ether solution, the precipitate reduced pressure at room temperature, grind powder.
Pharmaceutical preparation the best of the present invention contains the above-mentioned A.chinensis Planch. root effective site of 40-60% weight ratio.
Medicine of the present invention also contains conventional medicine excipient except containing described A.chinensis Planch. root effective site, for example, and solvent, filler, binding agent, disintegrating agent, solubilizing agent, thickening agent, correctives, antiseptic, wetting agent, lubricant etc.
The said pharmaceutical preparation of the present invention according to the preparation process of routine, can be made any pharmaceutical dosage form that can use clinically, as, tablet, unguentum, oral liquid, injection, suspensoid, pill, powder, eye drop, spongaion, liniment, cutaneous permeable agent, patch, capsule, granule, suppository etc.
The preparation method of medicine eye drop of the present invention is as follows:
Get the Fructus actinidiae chinensis heel piece, clean, add the alcohol dipping 2 times of 5 times of amounts 30%, each 24 hours, leave standstill, get supernatant, merge, add ethanol and transfer to that to contain amount of alcohol be 72%, left standstill 24 hours, centrifugal, precipitate is also respectively washed once with ethanol, the dehydrated alcohol of 5 times of amounts 72%, discards washing liquid, precipitate adds the washing of 3 times of amount ether once again, discard ether solution, the precipitate reduced pressure at room temperature, grind powder.Coarse powder adds the dissolving of injection water, and is centrifugal, gets supernatant, through the microporous filter membrane classified filtering, get the filtrate under the 0.45 μ filter membrane, add 0.03% ethyl hydroxybenzoate and an amount of sodium chloride, add the injection water and transfer to every milliliter to contain polysaccharide be 1 milligram solution, filter, aseptic potting, promptly.
In the above-mentioned method for making, after coarse powder added the dissolving of injection water, the preferred commentaries on classics with mulser 10000 earlier stirred 3 minutes, with 25000 rev/mins centrifugal 1 hour, incline and get supernatant, the precipitation add again the injection water an amount of, centrifugal again 1 hour, get supernatant and last time supernatant merging, then, through the microporous filter membrane classified filtering, get the filtrate under the 0.45 μ filter membrane again, add 0.03% ethyl hydroxybenzoate and an amount of sodium chloride, adding the injection water transfers to every milliliter to contain polysaccharide is 1 milligram solution, filter, aseptic potting, promptly.
In the above-mentioned method for making, the addition of sodium chloride reaches the required amount of isoosmotic pressure with finished product and is as the criterion.
The drug action of said medicine mainly depends on the effective site of being extracted from Chinese Radix Actinidiae Chinensis portion, because the Fructus actinidiae chinensis root contains plurality of active ingredients, screening a kind of rational extracting method, therefrom obtain to have the effective site of required drug action, is an important content of the present invention.The extracting method of A.chinensis Planch. root effective site of the present invention is as follows:
Get the Fructus actinidiae chinensis heel piece, add alcohol dipping 1-3 time that 2-8 doubly measures 20-50%, each 18-30 hour, get supernatant, merge, add ethanol and transfer to that to contain amount of alcohol be 60-95%, leave standstill, centrifugal, precipitate is also respectively washed once with ethanol, dehydrated alcohol that 2-7 doubly measures 50-80%, discards washing liquid, precipitate adds 2-4 again and doubly measures the ether washing once, discard ether solution, the precipitate reduced pressure at room temperature, grind powder.
The preferred extracting method of A.chinensis Planch. root effective site of the present invention is:
Get the Fructus actinidiae chinensis heel piece, clean, add the alcohol dipping 2 times of 5 times of amounts 30%, each 24 hours, leave standstill, get supernatant, merge, add ethanol and transfer to that to contain amount of alcohol be 72%, left standstill 24 hours, centrifugal, precipitate is also respectively washed once with ethanol, the dehydrated alcohol of 5 times of amounts 72%, discards washing liquid, precipitate adds the washing of 3 times of amount ether once again, discard ether solution, the precipitate reduced pressure at room temperature, grind powder.
The inventive method drug prepared has pharmacological action widely, and its main pharmacodynamics experiment effect is as follows:
One, encourages healthy trends raise immunity
1, promotes that the DNA of mice spleen, thymocyte cell is synthetic.
2, to the influence of human T-cell and subgroup thereof
A.chinensis Planch. root effective site of the present invention can stimulate people's T lymphocyte, and the outer blood T4 cell number that improves hepatitis B patient is had certain effect.
3, induce interleukin-22 (IL-2)
A.chinensis Planch. root effective site of the present invention can make that the IL-2 activity obviously improves than matched group in the spleen cell cultures supernatant.
4, induce M
φProduce interleukin-11 (IL-1)
Experimental result shows that A.chinensis Planch. root effective site of the present invention can significantly promote mice M
φDischarge IL-1.
5, to the effect of NK cell (NK) cell
Experiment shows that A.chinensis Planch. root effective site of the present invention can activate the NK cell activity.
6, the influence that tardy super quick (DTH) reacted
Experiment shows that medicine of the present invention can recover tardy super quick (DTH) reaction that has been suppressed by cyclophosphamide effectively.
7, to special rosette forming cell and antibody forming cell's influence
Experiment shows that medicine of the present invention can obviously increase special rosette forming cell (SRFC) number, has no effect but antagonist forms cell (PFC).
Two, dispel epidemic disease, enhancing body anti-infective ability
Medicine experiment in vitro of the present invention all has inhibitory action to 11 strains (comprising DNA viruses and RNA viruses) of five kinds of viruses such as herpes simplex virus.Then invalid to vesicular stomatitis virus and poliovirus.In the body the deadly of single bleb, influenza infection there is obvious protective effect, and can inducement interferon.Curative effect to rabbit experiment herpes simplex virus keratitis is better than the Western medicine iodouracil desoxyriboside.Therefore, medicine of the present invention also is a kind of anti virus herb preparation, and causing death of pathogenic infection also had obvious protective effect.
Three, dispersing swelling and dissipating binds, inhibition tumor
Medicine vivo medicine-feeding of the present invention has inhibitory action to mice-transplanted tumor EAC, Heps, P388.
The clinical research result of medicine of the present invention is as follows:
1, medicine of the present invention shows that to the I phase experiment of normal volunteer's 40 human eyes medicine of the present invention is to the human eye nonirritant.Observation of curative effect of initial step of II to the herpes simplex keratitis of 46 routine human eyes shows that medicine of the present invention is better than the Western medicine iodouracil desoxyriboside, can shorten healing period, improves cure rate.
2, medicine of the present invention shows the therapeutic outcome of 89 routine HIV sufferers, and long-term (three months) intramuscular injection is except that minority case one is crossed heat pyrexia and the local pain no obvious toxicity.Medicine of the present invention share separately or with Chinese medicine, has obtained the effect that improves symptom and adjust the cellular immune function curative effect, and the cloudy commentaries on classics of HIV serum antibody appears in the minority case.
3, medicine of the present invention shows the preliminary therapeutic outcome of 9 routine hepatitis B patients, to adjusting cellular immune function, improving liver function and symptom has certain effect.
Embodiment 1 extracts the effective site of A.chinensis Planch. root
Get Fructus actinidiae chinensis heel piece 1000 gram, clean, add the alcohol dipping 2 times of 5 times of amounts 30%, each 24 hours, leave standstill, get supernatant, merge, add ethanol and transfer to that to contain amount of alcohol be 72%, left standstill 24 hours, centrifugal, precipitate is also respectively washed once with ethanol, the dehydrated alcohol of 5 times of amounts 72%, discards washing liquid, precipitate adds the washing of 3 times of amount ether once again, discard ether solution, the precipitate reduced pressure at room temperature grinds to such an extent that powder 100 restrains.
Embodiment 2 preparations medicine eye drop of the present invention
Get the coarse powder of embodiment 1 preparation, add the dissolving of injection water, change with mulser 10000 earlier and stirred 3 minutes, centrifugal 1 hour with 25000 rev/mins, incline and get supernatant, precipitation adds centrifugal more in right amount 1 hour of injection water again, get supernatant and last time supernatant merging, then, again through the microporous filter membrane classified filtering, get the filtrate under the 0.45 μ filter membrane, add 0.03% ethyl hydroxybenzoate and an amount of sodium chloride (addition of sodium chloride is that finished product reaches the required amount of isoosmotic pressure), add the injection water and transfer to every milliliter to contain polysaccharide be 1 milligram solution, filter, aseptic potting, promptly.
The preparation of embodiment 3 medicine capsules of the present invention
Get Fructus actinidiae chinensis heel piece 1000 gram, clean, add the alcohol dipping 2 times of 5 times of amounts 30%, each 24 hours, leave standstill, get supernatant, merge, add ethanol and transfer to that to contain amount of alcohol be 72%, leave standstill 24 hours, centrifugal, precipitate is also respectively washed once with ethanol, the dehydrated alcohol of 5 times of amounts 72%, discard washing liquid, precipitate adds the washing of 3 times of amount ether once again, discards ether solution, the precipitate reduced pressure at room temperature, grind, cross 100 mesh sieves, get powder 100 grams, gained medicated powder and starch is even with 1: 1 mixed, encapsulated, every gram pastille 1 gram.
The preparation of embodiment 4 drug injections of the present invention
Get coarse powder 500 grams of embodiment 1 preparation, add the dissolving of injection water, change with mulser 10000 earlier and stirred 3 minutes, centrifugal 1 hour with 25000 rev/mins, incline and get supernatant, precipitation adds centrifugal more in right amount 1 hour of injection water again, get supernatant and last time supernatant merging, then, again through the microporous filter membrane classified filtering, get the filtrate under the 0.45 μ filter membrane, add 0.03% ethyl hydroxybenzoate and an amount of sodium chloride (addition of sodium chloride is that finished product reaches the required amount of isoosmotic pressure), add the injection water and transfer to every milliliter to contain polysaccharide be 1 milligram solution, filter, aseptic potting, promptly.
The preparation of embodiment 5 medicinal tablets of the present invention
Get coarse powder 1000 grams of embodiment 1 preparation, add excipient starch, mix homogeneously, with the ethanol pelletize, granulate as the tablet machine tabletting, makes tablet.
Claims (4)
1, the purposes of A.chinensis Planch. root in the medicine of preparation acquired immune deficiency syndrome (AIDS).
2, the purposes of the effective site of A.chinensis Planch. root in the medicine of preparation treatment hepatitis B is characterized in that the extracting method of this effective site is as follows:
Get the Fructus actinidiae chinensis heel piece, add alcohol dipping 1-3 time that 2-8 doubly measures 20-50%, each 18-30 hour, get supernatant, merge, add ethanol and transfer to that to contain amount of alcohol be 60-95%, leave standstill, centrifugal, precipitate is also respectively washed once with ethanol, dehydrated alcohol that 2-7 doubly measures 50-80%, discards washing liquid, precipitate adds 2-4 again and doubly measures the ether washing once, discard ether solution, the precipitate reduced pressure at room temperature, grind powder.
3,, it is characterized in that the extracting method of this effective site is as follows according to the purposes of claim 2:
Get the Fructus actinidiae chinensis heel piece, add alcohol dipping 1-3 time that 3-6 doubly measures 25-40%, each 20-28 hour, get supernatant, merge, add ethanol and transfer to that to contain amount of alcohol be that 65-80% leaves standstill, centrifugal, precipitate is also respectively washed once with ethanol, dehydrated alcohol that 3-6 doubly measures 60-78%, discard washing liquid, precipitate adds 2-4 again and doubly measures the ether washing once, discards ether solution, the precipitate reduced pressure at room temperature, grind powder.
4,, it is characterized in that the extracting method of this effective site is as follows according to the purposes of claim 2:
Get the Fructus actinidiae chinensis heel piece, clean, add the alcohol dipping 2 times of 5 times of amounts 30%, each 24 hours, leave standstill, get supernatant, merge, add ethanol and transfer to that to contain amount of alcohol be 72%, left standstill 24 hours, centrifugal, precipitate is also respectively washed once with ethanol, the dehydrated alcohol of 5 times of amounts 72%, discards washing liquid, precipitate adds the washing of 3 times of amount ether once again, discard ether solution, the precipitate reduced pressure at room temperature, grind powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96120260A CN1067258C (en) | 1996-10-30 | 1996-10-30 | Medicinal preparation with extractive from yangtao root and preparing process thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96120260A CN1067258C (en) | 1996-10-30 | 1996-10-30 | Medicinal preparation with extractive from yangtao root and preparing process thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1156624A CN1156624A (en) | 1997-08-13 |
| CN1067258C true CN1067258C (en) | 2001-06-20 |
Family
ID=5126229
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96120260A Expired - Fee Related CN1067258C (en) | 1996-10-30 | 1996-10-30 | Medicinal preparation with extractive from yangtao root and preparing process thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1067258C (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT503521A1 (en) | 2006-05-05 | 2007-11-15 | Omnica Gmbh | USE OF AN EXTRACT OF KIWI FRUIT |
| CN100457116C (en) * | 2006-06-06 | 2009-02-04 | 赵正福 | Cercopithecoidealin with anti-tumor function, its preparation and use |
| CN101502542B (en) * | 2009-03-17 | 2011-01-05 | 江南大学 | Method for extracting Chinese actinidia root extract and application thereof for resisting liver damage |
| CN104721242A (en) * | 2015-02-07 | 2015-06-24 | 新乡学院 | Method for extracting natural plant antineoplastic drugs |
| CN104738102B (en) * | 2015-03-26 | 2017-12-15 | 杨凌农科大无公害农药研究服务中心 | Chinese gooseberry root bark extract is used for the application for preparing anti-plant virus agent |
| CN105943571B (en) * | 2016-07-13 | 2020-06-02 | 秦小波 | Preparation method and application of kiwifruit waste anti-tumor extract |
| CN106692177A (en) * | 2016-09-27 | 2017-05-24 | 张舸 | Anti-influenza and immune polysaccharide preparation lozenges and preparation method thereof |
-
1996
- 1996-10-30 CN CN96120260A patent/CN1067258C/en not_active Expired - Fee Related
Non-Patent Citations (5)
| Title |
|---|
| 《中国医药学报》10(1) 1995.1.1 黄骏等，919糖浆治疗慢性乙型肝炎临床研究 * |
| 《新中医》24(2) 1992.1.1 郭翔等，肝泰92治疗慢性乙型肝炎的临床观察 * |
| 《新中医》24(2) 1992.1.1 郭翔等，肝泰92治疗慢性乙型肝炎的临床观察;《中国医药学报》10(1) 1995.1.1 黄骏等，919糖浆治疗慢性乙型肝炎临床研究;中草药17 9 1986.1.1 张菊明等，中华猕猴桃多矿复合物的抗感染免疫作用;中国医药学报 8 6 1993.1.1 陈良良等，消冒障滴眼液治疗单纯疱疹病毒性角膜炎的临床研究 * |
| 中国医药学报 8 6 1993.1.1 陈良良等，消冒障滴眼液治疗单纯疱疹病毒性角膜炎的临床研究 * |
| 中草药17 9 1986.1.1 张菊明等，中华猕猴桃多矿复合物的抗感染免疫作用 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1156624A (en) | 1997-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1283258C (en) | Medicine for preventing fibrous liver and preparing method thereof | |
| CN101049424A (en) | Medication for treating infection in respiratory system | |
| WO2006118553A1 (en) | Compositions comprising natural agents for the treatment of hiv-associated opportunistic infections and complications and methods for preparing and using compositions comprising natural agents | |
| CN1067258C (en) | Medicinal preparation with extractive from yangtao root and preparing process thereof | |
| CN101862356A (en) | Antineoplastic medicament extracted from Chinese actinidia roots and preparation method thereof | |
| CN1243743A (en) | Medicine for treating chronic hepatism and its preparing process | |
| CN101411779B (en) | Chinese medicine effective component composition for treating liver cancer and method for preparing the same | |
| CN1105570C (en) | Medicinal composition for curing arthritis and osteoarthropathy and its preparing method | |
| CN1272054C (en) | Medicine for treating diabetes and its preparing process | |
| CN101357213B (en) | Compound cantharis liquid formulation and preparation method thereof | |
| CN1159038C (en) | 'Shuanghuang Yupi' cream for skin healing | |
| CN1060051C (en) | Anti-cancer compn. and prepn. thereof | |
| CN1212143C (en) | Medicine for treating coronary disease and its preparation method | |
| CN1927381A (en) | Medicine comprising rilmenidine | |
| CN1219539C (en) | Immune regulator prepared from waste material in preparing Mailuoning injection process and its use in producing medicine | |
| CN1394614A (en) | Health-care product capable of regulating blood-lipid and its preparation method | |
| CN1490014A (en) | Mangiferin preparation and production thereof | |
| CN1644203A (en) | Oral preparation of red common stone crop polysaccharide and its making method | |
| CN1242755C (en) | Chinese traditional medicine extracts and its preparation and application in pharmacy | |
| CN1301722C (en) | Sow thistle extract, preparing process and application thereof | |
| CN1257735A (en) | Medicine for treating constipation and its preparing process | |
| CN1470262A (en) | Shuanghuanglian preparation and its preparing method | |
| CN1857411A (en) | Chinese medicine capsule for treating AIDS and its preparing method | |
| CN1105562C (en) | Compound injection for treating cancer and prepn. method therefor | |
| CN1557418A (en) | Composite Chinese medicine gelling agent for treating osteo arthropathy and preparing method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C56 | Change in the name or address of the patentee |
Owner name: ZHEJIANG UNIVERSITY OF TRADITIONAL CHINESE MEDICIN Free format text: FORMER NAME OR ADDRESS: ZHEJIANG COLLEGE OF TRADITIONAL CHINESE MEDICINE |
|
| CP03 | Change of name, title or address |
Address after: Hangzhou Province Youth Street, Zhejiang Province, Zhejiang University Patentee after: Zhejiang Chinese Medicine University Address before: Hangzhou Province Youth Street, Zhejiang Province, Zhejiang University Patentee before: Zhejiang Chinese Medical College |
|
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20010620 Termination date: 20101030 |